Maryland's Defense Patent Database

The defense community in Maryland is an R&D powerhouse.

Use this database to see the innovative patents that are poised for commercialization.

Recombinant Plasmodium vivax merozoite protein-1 p42 vaccine

Patent image
MRDC

In this application is the expression and purification of a recombinant Plasmodium vivax (SalI) PvMSP-1 p42. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant PvMSP-1 p42 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.

Inventors: 
Lanar, David E.; Dutta, Sheetij; Ware, Lisa A.
Patent Number: 
Technical domain: 
Biotechnology and Healthcare
FIle Date: 
2002-03-18
Grant Date: 
2006-12-19
Grant time: 
1,737 days
Grant time percentile rank: 
32
Claim count percentile rank: 
4
Citations percentile rank: 
1
'Cited by' percentile rank: 
1
Assignee: 
US ARMY